Skip to content
GLP-1 Decoder

Liraglutide FDA Approval: Every Indication and Date

Fda liraglutide: what happened, what it means for patients, and where to read the record.

Active ingredient
liraglutide

A quick look at Saxenda

How long it remains in the body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours: after 13 h, half is gone, and after five half-lives (2.7 d), about 3% remains.

Weight loss in the main trial
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

For SCALE Obesity and Prediabetes, 56 weeks, the body-weight result was 7.4%, compared with 3% for placebo.

Sources: FDA label (DailyMed).